Attention deficit hyperactivity disorder (ADHD) wit Tic Disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: Intervention group1: Patients will receive 0.5 to 1.4mg Atomoxetine and Aripiprazole for 2 month. Intervention 2: Intervention group2: Patients will receive 0.5 to 1.4mg Atomoxetine an
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Inclusion criteria
Inclusion criteria: Age 6 to 18 years Concomitant hyperactivity disorder - Congestive disorder and tick disorders Diagnosis of a child and adolescent psychiatrist Conscious Satisfaction of Parents and Adolescents for Child Participation in the Study
Exclusion criteria
Exclusion criteria: History of treatment failure with mentioned drug combinations History of any new drug side effects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tic Severity. Timepoint: Before the intervention, six months after the intervention. Method of measurement: Yale Global Tic Severity Scale (YGTTS).;ADHD Severity. Timepoint: Before the intervention, six months after the intervention. Method of measurement: ADHD Rating Scale-IV. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Seyed Golamreza Noorazar
Tabriz University of Medical Sciences
Outcome results
None listed